KODIAK SCIENCES INC. Shares Outstanding (Cover Page)
KODIAK SCIENCES INC. (KOD) had Shares Outstanding (Cover Page) of 62.85 million shares as of 2026-08-06, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-06: Entity Common Stock, Shares Outstanding 62.85M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 62.58M shares.
- 2026-03-19: Entity Common Stock, Shares Outstanding 61.85M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 53.05M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 62.85M shares 10-Q · filed 2026-08-13 |
| 2026-04-30 | 62.58M shares 10-Q · filed 2026-05-07 |
| 2026-03-19 | 61.85M shares 10-K · filed 2026-03-31 |
| 2025-11-06 | 53.05M shares 10-Q · filed 2025-11-13 |
| 2025-08-06 | 52.82M shares 10-Q · filed 2025-08-13 |
| 2025-05-07 | 52.76M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 52.75M shares 10-K · filed 2025-03-27 |
| 2024-10-31 | 52.62M shares 10-Q · filed 2024-11-14 |
| 2024-07-31 | 52.61M shares 10-Q · filed 2024-08-14 |
| 2024-04-30 | 52.53M shares 10-Q · filed 2024-05-15 |
| 2024-02-29 | 52.51M shares 10-K · filed 2024-03-28 |
| 2023-10-31 | 52.47M shares 10-Q · filed 2023-11-14 |
| 2023-07-31 | 52.45M shares 10-Q · filed 2023-08-14 |
| 2023-05-01 | 52.36M shares 10-Q · filed 2023-05-15 |
| 2023-02-28 | 52.34M shares 10-K · filed 2023-03-28 |
| 2022-10-31 | 52.31M shares 10-Q · filed 2022-11-09 |
| 2022-07-29 | 52.04M shares 10-Q · filed 2022-08-09 |
| 2022-04-29 | 51.95M shares 10-Q · filed 2022-05-10 |
| 2022-02-18 | 51.93M shares 10-K · filed 2022-03-01 |
| 2021-10-29 | 51.72M shares 10-Q · filed 2021-11-09 |
| 2021-07-31 | 51.45M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 51.26M shares 10-Q · filed 2021-05-10 |
| 2021-02-19 | 51.16M shares 10-K · filed 2021-03-01 |
| 2020-10-31 | 44.80M shares 10-Q · filed 2020-11-09 |
| 2020-07-31 | 44.71M shares 10-Q · filed 2020-08-10 |
| 2020-04-30 | 44.48M shares 10-Q · filed 2020-05-11 |
| 2020-03-02 | 44.42M shares 10-K · filed 2020-03-16 |
| 2019-10-31 | 37.06M shares 10-Q · filed 2019-11-12 |
| 2019-07-31 | 36.93M shares 10-Q · filed 2019-08-14 |
| 2019-04-30 | 36.91M shares 10-Q · filed 2019-05-15 |
| 2019-03-06 | 36.91M shares 10-K · filed 2019-03-27 |
| 2018-11-14 | 36.83M shares 10-Q · filed 2018-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |